ELUTIA INC.

Develops drug-eluting biologics to reduce complications from medical implants.

ELUT | US

Overview

Corporate Details

ISIN(s):: US05479K1060
LEI:
Country:: United States of America
Address:: 12510 PROSPERITY DRIVE, 20904 SILVER SPRING
Website:: https://elutia.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Elutia Inc. is a commercial-stage company that develops and commercializes drug-eluting biologic products to improve compatibility between medical devices and patients. The company's proprietary drug-eluting biomaterial platforms combine natural biologic materials with extended-release antibiotics to address post-surgical complications from implant failures. Its key offerings include CanGaroo, an acellular device envelope for implantable electronics like pacemakers and neurostimulators, and SimpliDerm, a human acellular dermal matrix for soft tissue reconstruction. These products are designed to mitigate fibrotic responses, ensure implant stability, and support wound healing. Formerly known as Aziyo Biologics, the company rebranded to Elutia to reflect its strategic focus on drug-eluting biomatrices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELUTIA INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELUTIA INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ELUTIA INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Quantum Genomics Biopharma developing cardiovascular treatments, now in judicial liquidation.	France	ALQGC
QuidelOrtho Corp Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.	United States of America	QDEL
Quince Therapeutics, Inc. Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.	United States of America	QNCX
Quoin Pharmaceuticals, Ltd. Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.	United States of America	QNRX
Quratis Inc. Develops infectious disease vaccines and offers biologics CDMO services for global health.	South Korea	348080
Radiopharm Theranostics Ltd Developing first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer.	United States of America	RADX
Rallybio Corp Develops therapies for severe and rare diseases in hematology and complement dysregulation.	United States of America	RLYB
Rani Therapeutics Holdings, Inc. Develops a capsule to convert injectable biologics into oral pills for chronic diseases.	United States of America	RANI
Rapport Therapeutics, Inc. Developing precision small molecule medicines for Central Nervous System (CNS) disorders.	United States of America	RAPP
RAPT Therapeutics, Inc. Developing immune-targeting therapies for inflammatory and immunologic diseases.	United States of America	RAPT